Deep Medicine Acquisition (DMAQ) Short Interest Ratio & Short Volume

Short interest is the volume of Deep Medicine Acquisition shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 5,700 shares of DMAQ short. 6.64% of Deep Medicine Acquisition's shares are currently sold short. Learn More on Deep Medicine Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.64% of Deep Medicine Acquisition's floating shares are currently sold short.

Deep Medicine Acquisition saw a drop in short interest in September. As of September 15th, there was short interest totaling 5,700 shares, a drop of 30.5% from the previous total of 8,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Deep Medicine Acquisition currently has issued a total of 4,358,000 shares. Some of Deep Medicine Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Deep Medicine Acquisition currently has a public float of 85,900 shares.

6.64% of Deep Medicine Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "unclassified" compare to Deep Medicine Acquisition: Healthcare AI Acquisition Corp. (0.08%), Quantum FinTech Acquisition Co. (0.13%), Redwoods Acquisition Corp. (8.16%), Aurora Technology Acquisition Corp. (0.91%), EF Hutton Acquisition Co. I (0.09%), Next.e.GO (1.93%), Concord Acquisition Corp II (0.21%), Mountain Crest Acquisition Corp. V (0.03%), Broad Capital Acquisition Corp. (0.01%), Western Acquisition Ventures Corp. (0.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

Short selling DMAQ is an investing strategy that aims to generate trading profit from Deep Medicine Acquisition as its price is falling. DMAQ shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Deep Medicine Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMAQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMAQ, twice per month. The most recent reporting period available is September, 15 2023.